» Articles » PMID: 16870812

The Risk of Relapses in Multiple Sclerosis During Systemic Infections

Overview
Journal Neurology
Specialty Neurology
Date 2006 Jul 28
PMID 16870812
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To assess the risk of multiple sclerosis (MS) relapses, MRI activity, and T cell responses during systemic infections (SI) in patients with MS.

Methods: The authors prospectively studied 60 patients with MS. Twenty patients were evaluated with sequential MRI on initial visit, and 2 and 12 weeks later. Blood samples were collected at first infection symptom and 2, 5, 12, and 24 weeks later, and production of IL-4, IL-10, IL-12, IFN-gamma, TNFalpha, VLA-4, LFA-1, MMP-9, and MMP-2 were measured after infectious antigens (Ag) stimulation.

Results: Increased risk of relapse and MRI activity were observed during SI. Numbers of IFN-gamma, TNFalpha, and IL-12 secreting cells, serum concentrations of MMP-9, and expression of VLA-4 and LFA-1 after PBMC viral or bacterial Ag stimulation were higher in samples collected during exacerbations associated to SI. Transwell analysis demonstrated that soluble factors produced during viral stimulation have little effect on myelin specific T cells activity. In contrast, PBMC viral stimulation in the presence of cognate myelin Ag induces maximal effector responses at 20 to 30 times lower than the Ag alone.

Conclusions: There was a significant association between systemic infections and risk of MS relapse, increased MRI activity, and T cells activation. Furthermore, infectious agents increased myelin specific T-cells sensitivity to cognate Ag.

Citing Articles

SARS-CoV-2 infection and risk of subsequent demyelinating diseases: national register-based cohort study.

Montgomery S, Vingeliene S, Li H, Backman H, Udumyan R, Jendeberg J Brain Commun. 2024; 6(6):fcae406.

PMID: 39659973 PMC: 11629974. DOI: 10.1093/braincomms/fcae406.


Long-Term Observation of SARS-CoV-2 Vaccination Response upon High Efficacy Treatment in Multiple Sclerosis-A Real-World Scenario.

Schraad M, Runkel S, Hitzler W, Protopapa M, Bittner S, Uphaus T Vaccines (Basel). 2024; 12(3).

PMID: 38543930 PMC: 10974098. DOI: 10.3390/vaccines12030296.


Stressful life events and depression and fatigue in people with multiple sclerosis: a cross-sectional analysis of an international cohort.

Reece J, Neate S, Davenport R, Milanzi E, Nag N, Bevens W Acta Neurol Belg. 2023; 124(2):457-466.

PMID: 37770791 PMC: 10965589. DOI: 10.1007/s13760-023-02390-z.


The association of upper respiratory infections with neuro-radiological course and attack rate of multiple sclerosis: Results from a large prospective cohort.

Ghasemi M, Farazandeh D, Amini B, Sedaghat M, Najafi A, Kakhki S Mult Scler J Exp Transl Clin. 2023; 9(3):20552173231196992.

PMID: 37767104 PMC: 10521289. DOI: 10.1177/20552173231196992.


COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: A case-control study.

Rahmani M, Naser Moghadasi A, Shahi S, Eskandarieh S, Azizi H, Hasanzadeh A Med Clin (Engl Ed). 2023; 160(5):187-192.

PMID: 36883067 PMC: 9983351. DOI: 10.1016/j.medcle.2022.06.021.